Moritaki et al. reported that PTEN was mutated in the KP-N-AYR neuroblastoma cell line, which was established from bone marrow metastases of a 21⁄2 year old patient with stage 4 neuroblastoma at time of recurrence following chemotherapy. The gene discussed is PTEN; the disease is neuroblastoma.